Safety, tolerability and pharmacokinetics of multiple ascending doses of AZD8871 in healthy subjects

Trial Identifier:	D6640C00003
Sponsor:	AstraZeneca
Collaborator:	PAREXEL
NCTID::	NCT02814656
Start Date:	June 2016
Primary Completion Date:	November 2016
Study Completion Date:	November 2016
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.